{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:14:36Z","timestamp":1788545676898,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s11095-026-04100-9","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:17:07Z","timestamp":1778523427000},"page":"2423-2448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Design and Biopharmaceutical Evaluation of a Chimeric Nanoparticle Vaccine for Targeted Delivery against BK Polyomavirus"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9138-3792","authenticated-orcid":false,"given":"Amin","family":"Zahmatkesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1726-8316","authenticated-orcid":false,"given":"Seyed Nooreddin","family":"Faraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5881-6796","authenticated-orcid":false,"given":"Seyed Younes","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-8621","authenticated-orcid":false,"given":"Ramin","family":"Yaghobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"4100_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101655","author":"MR Foroudi","year":"2022","unstructured":"Foroudi MR, Yaghobi R, Afshari A, Roozbeh J, Miresmaeili SM, Javid A. The effect of BK polyomavirus large T antigen on CD4 and CD8 T cells in kidney transplant recipients. Transplant Immunol. 2022. https:\/\/doi.org\/10.1016\/j.trim.2022.101655.","journal-title":"Transplant Immunol"},{"issue":"1","key":"4100_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-024-02620-7","volume":"22","author":"S Bizhani","year":"2025","unstructured":"Bizhani S, Afshari A, Yaghobi R. Bk polyomavirus and acute kidney injury in transplant recipients: signaling pathways and molecular mechanisms. Virol J. 2025;22(1):2.","journal-title":"Virol J"},{"issue":"1","key":"4100_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93503-6","volume":"15","author":"M Changizi","year":"2025","unstructured":"Changizi M, Motalleb G, Yaghobi R, Afshari A, Roozbeh J. The impact of gamma interferon on Bk virus candidate microRNAs and related miRNAs in kidney transplant patients with Bk infection. Sci Rep. 2025;15(1):8880.","journal-title":"Sci Rep"},{"issue":"3","key":"4100_CR4","volume":"6","author":"R Torres","year":"2021","unstructured":"Torres R, Montero C, Escobar C, Reina M, Acevedo A, Yomayusa N, et al. Early detection strategy of BK polyomavirus nephropathy in patients undergoing renal transplant: a single-center retrospective study. Transplant Rep. 2021;6(3):100077.","journal-title":"Transplant Rep"},{"issue":"2","key":"4100_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1089\/vim.2015.0099","volume":"29","author":"A Kariminik","year":"2016","unstructured":"Kariminik A, Yaghobi R, Dabiri S. Innate immunity and Bk virus: prospective strategies. Viral Immunol. 2016;29(2):74\u201382.","journal-title":"Viral Immunol"},{"key":"4100_CR6","doi-asserted-by":"crossref","unstructured":"Yaghobi R, Afshari A, Roozbeh J. Host and viral RNA dysregulation during BK polyomavirus infection in kidney transplant recipients. Wiley Interdisciplinary Reviews: RNA. 2022:e1769.","DOI":"10.1002\/wrna.1769"},{"key":"4100_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147567","volume":"878","author":"I Sahragard","year":"2023","unstructured":"Sahragard I, Mohammadi A, Yaghobi R, Pakfetrat M, Afshari A, Sharifi H, et al. The relation of NCCR variations and host transcription factors gene regulation in BK polyomavirus infected kidney transplant patients. Gene. 2023;878:147567.","journal-title":"Gene"},{"key":"4100_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148376","author":"I Sahragard","year":"2024","unstructured":"Sahragard I, Yaghobi R, Mohammadi A, Afshari A, Pakfetrat M, Karimi MH, et al. Impact of BK polyomavirus NCCR variations in post kidney transplant outcomes. Gene. 2024. https:\/\/doi.org\/10.1016\/j.gene.2024.148376.","journal-title":"Gene"},{"issue":"4","key":"4100_CR9","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1128\/JVI.01918-09","volume":"84","author":"JA Jordan","year":"2010","unstructured":"Jordan JA, Manley K, Dugan AS, O\u2019Hara BA, Atwood WJ. Transcriptional regulation of BK virus by nuclear factor of activated T cells. J Virol. 2010;84(4):1722\u201330.","journal-title":"J Virol"},{"issue":"6","key":"4100_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/QCO.0000000000000888","volume":"35","author":"BZ Sim","year":"2022","unstructured":"Sim BZ, Yong KY, Slavin MA, Yong MK. Risk factors and outcome of concurrent and sequential multiviral cytomegalovirus, Epstein\u2013Barr virus, BK virus, adenovirus and other viral reactivations in transplantation. Curr Opin Infect Dis. 2022;35(6):536\u201344.","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"4100_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/01.tp.0000269706.59977.a5","volume":"84","author":"CB Drachenberg","year":"2007","unstructured":"Drachenberg CB, Hirsch HH, Papadimitriou JC, Gosert R, Wali RK, Munivenkatappa R, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84(3):323\u201330.","journal-title":"Transplantation"},{"issue":"5","key":"4100_CR12","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.3892\/mmr.2017.7353","volume":"16","author":"Y Yu","year":"2017","unstructured":"Yu Y, Zhong J, Peng L, Wang B, Li S, Huang H, et al. Tacrolimus downregulates inflammation by regulating pro\u2011\/anti\u2011inflammatory responses in LPS\u2011induced keratitis. Mol Med Rep. 2017;16(5):5855\u201362.","journal-title":"Mol Med Rep"},{"issue":"1","key":"4100_CR13","first-page":"94","volume":"73","author":"W Krajewski","year":"2020","unstructured":"Krajewski W, Kami\u0144ska D, Poterek A, Ma\u0142kiewicz B, K\u0142ak J, Zdrojowy R, et al. Pathogenicity of Bk virus on the urinary system. Cent Eur J Urol. 2020;73(1):94.","journal-title":"Cent Eur J Urol"},{"issue":"2","key":"4100_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/jcp.20300","volume":"204","author":"D Fioriti","year":"2005","unstructured":"Fioriti D, Videtta M, Mischitelli M, Degener A, Russo G, Giordano A, et al. The human polyomavirus BK: Potential role in cancer. J Cell Physiol. 2005;204(2):402\u20136.","journal-title":"J Cell Physiol"},{"key":"4100_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.153146","author":"A Zahmatkesh","year":"2025","unstructured":"Zahmatkesh A, Yaghoobi R, Sahragard I, Afshari A, Hosseini SY, Kargar M. Measuring mRNA expression level of viral genes, IRF3\/7 and TLR7\/8 during BK polyomavirus infection in kidney transplant recipients. Immunobiology. 2025. https:\/\/doi.org\/10.1016\/j.imbio.2025.153146.","journal-title":"Immunobiology"},{"key":"4100_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2023.101884","volume":"80","author":"MR Foroudi","year":"2023","unstructured":"Foroudi MR, Yaghobi R, Afshari A, Roozbeh J, Miresmaeili SM, Javid A. The effect of the BK polyomavirus large T antigen on the function and maturity of the CD4+ T cell subsets in kidney transplant recipients. Transplant Immunol. 2023;80:101884.","journal-title":"Transplant Immunol"},{"key":"4100_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/TRRM.S188021","volume":"11","author":"SA Muhsin","year":"2019","unstructured":"Muhsin SA, Wojciechowski D. BK virus in transplant recipients: current perspectives. Transplant Research and Risk Management. 2019;11:47.","journal-title":"Transplant Research and Risk Management"},{"issue":"3","key":"4100_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/v13030487","volume":"13","author":"C-L Shen","year":"2021","unstructured":"Shen C-L, Wu B-S, Lien T-J, Yang A-H, Yang C-Y. BK polyomavirus nephropathy in kidney transplantation: balancing rejection and infection. Viruses. 2021;13(3):487.","journal-title":"Viruses"},{"issue":"26","key":"4100_CR19","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1016\/j.vaccine.2019.04.096","volume":"37","author":"V Kesherwani","year":"2019","unstructured":"Kesherwani V, Tarang S. An immunoinformatic approach to universal therapeutic vaccine design against BK virus. Vaccine. 2019;37(26):3457\u201363.","journal-title":"Vaccine"},{"issue":"7","key":"4100_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101257","volume":"23","author":"J Manzetti","year":"2020","unstructured":"Manzetti J, Weissbach FH, Graf FE, Unterstab G, Wernli M, Hopfer H, et al. BK polyomavirus evades innate immune sensing by disrupting the mitochondrial network and promotes mitophagy. iScience. 2020;23(7):101257.","journal-title":"iScience"},{"issue":"8","key":"4100_CR21","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/v12080824","volume":"12","author":"D McIlroy","year":"2020","unstructured":"McIlroy D, H\u00f6nemann M, Nguyen N-K, Barbier P, Peltier C, Rodallec A, et al. Persistent BK polyomavirus viruria is associated with accumulation of VP1 mutations and neutralization escape. Viruses. 2020;12(8):824.","journal-title":"Viruses"},{"issue":"10","key":"4100_CR22","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1681\/ASN.0000000000000457","volume":"35","author":"F Helle","year":"2024","unstructured":"Helle F, Aubry A, Morel V, Descamps V, Demey B, Brochot E. Neutralizing antibodies targeting BK polyomavirus: clinical importance and therapeutic potential for kidney transplant recipients. J Am Soc Nephrol. 2024;35(10):1425\u201333.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4100_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/s12879-019-4615-x","volume":"19","author":"J Bruminhent","year":"2019","unstructured":"Bruminhent J, Srisala S, Klinmalai C, Pinsai S, Watcharananan SP, Kantachuvesiri S, et al. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy. BMC Infect Dis. 2019;19(1):974.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"4100_CR24","first-page":"272","volume":"23","author":"N Noshadi","year":"2024","unstructured":"Noshadi N, Yaghoubi R, Forouzanfar M, Soleimanian S. Polyomavirus BK-Specific CD4+ T Cells Response to VP1 Stimulation in Kidney Transplant Recipients. Iran J Allergy Asthma Immunol. 2024;23(3):272\u201387.","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"1","key":"4100_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22646-7","volume":"12","author":"S Rashidi","year":"2022","unstructured":"Rashidi S, Faraji SN, Mamaghani AJ, Hatam S, Kazemi B, Bemani P, et al. Bioinformatics analysis for the purpose of designing a novel multi-epitope DNA vaccine against Leishmania major. Sci Rep. 2022;12(1):18119.","journal-title":"Sci Rep"},{"issue":"1","key":"4100_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03122-6","volume":"23","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Liu J, Peng C, Guo S, Wang B, Chen L, et al. Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine. J Nanobiotechnology. 2025;23(1):77.","journal-title":"J Nanobiotechnology"},{"key":"4100_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2021.214188","volume":"448","author":"AV Almeida","year":"2021","unstructured":"Almeida AV, Carvalho AJ, Pereira AS. Encapsulin nanocages: protein encapsulation and iron sequestration. Coord Chem Rev. 2021;448:214188.","journal-title":"Coord Chem Rev"},{"key":"4100_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.890622","volume":"13","author":"U Kar","year":"2022","unstructured":"Kar U, Khaleeq S, Garg P, Bhat M, Reddy P, Vignesh VS, et al. Comparative immunogenicity of bacterially expressed soluble trimers and nanoparticle displayed influenza hemagglutinin stem immunogens. Front Immunol. 2022;13:890622.","journal-title":"Front Immunol"},{"issue":"12","key":"4100_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121828","volume":"11","author":"S Chauhan","year":"2023","unstructured":"Chauhan S, Khasa YP. Challenges and opportunities in the process development of chimeric vaccines. Vaccines. 2023;11(12):1828.","journal-title":"Vaccines"},{"issue":"10","key":"4100_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"X Chen","year":"2013","unstructured":"Chen X, Zaro JL, Shen W-C. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev. 2013;65(10):1357\u201369.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"4100_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/v17040556","volume":"17","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ru Y, Zhao L, Hao R, Yang Y, Li Y, et al. Ferritin and encapsulin nanoparticles as effective vaccine delivery systems: boosting the immunogenicity of the African Swine Fever Virus C129R protein. Viruses. 2025;17(4):556.","journal-title":"Viruses"},{"issue":"1","key":"4100_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01216-8","volume":"10","author":"Y Ding","year":"2025","unstructured":"Ding Y, Li Y, Wu Z, Zhou Y, Guo Y, Tian S, et al. A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv. NPJ Vaccines. 2025;10(1):173.","journal-title":"NPJ Vaccines"},{"issue":"3","key":"4100_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7030088","volume":"7","author":"HA Dar","year":"2019","unstructured":"Dar HA, Zaheer T, Shehroz M, Ullah N, Naz K, Muhammad SA, et al. Immunoinformatics-aided design and evaluation of a potential multi-epitope vaccine against Klebsiella pneumoniae. Vaccines. 2019;7(3):88.","journal-title":"Vaccines"},{"issue":"2","key":"4100_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/v15020346","volume":"15","author":"S Khaleeq","year":"2023","unstructured":"Khaleeq S, Sengupta N, Kumar S, Patel UR, Rajmani RS, Reddy P, et al. Neutralizing efficacy of encapsulin nanoparticles against SARS-CoV2 variants of concern. Viruses. 2023;15(2):346.","journal-title":"Viruses"},{"issue":"D1","key":"4100_CR35","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2019","unstructured":"Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, et al. The immune epitope database (IEDB): 2018 update. Nucleic Acids Res. 2019;47(D1):D339\u201343.","journal-title":"Nucleic Acids Res"},{"key":"4100_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.intimp.2019.01.016","volume":"69","author":"SN Faraji","year":"2019","unstructured":"Faraji SN, Nejatollahi F, Tamaddon A-M, Mohammadi M, Aminsharifi AR. Generation and characterization of a specific single-chain antibody against DSPP as a prostate cancer biomarker: involvement of bioinformatics-based design of novel epitopes. Int Immunopharmacol. 2019;69:217\u201324.","journal-title":"Int Immunopharmacol"},{"key":"4100_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106864","volume":"158","author":"LD Naorem","year":"2023","unstructured":"Naorem LD, Sharma N, Raghava GP. A web server for predicting and scanning of IL-5 inducing peptides using alignment-free and alignment-based method. Comput Biol Med. 2023;158:106864.","journal-title":"Comput Biol Med"},{"key":"4100_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105297","volume":"143","author":"S Jain","year":"2022","unstructured":"Jain S, Dhall A, Patiyal S, Raghava GP. IL13Pred: a method for predicting immunoregulatory cytokine IL-13 inducing peptides. Comput Biol Med. 2022;143:105297.","journal-title":"Comput Biol Med"},{"key":"4100_CR39","doi-asserted-by":"crossref","unstructured":"Gupta S, Ansari HR, Gautam A, net OSDDCio, Raghava GP. Identification of B-cell epitopes in an antigen for inducing specific class of antibodies. Biology direct. 2013;8(1):27.","DOI":"10.1186\/1745-6150-8-27"},{"key":"4100_CR40","doi-asserted-by":"crossref","unstructured":"Lindner JM, Cornacchione V, Sathe A, Be C, Srinivas H, Riquet E, et al. Human memory B cells harbor diverse cross-neutralizing antibodies against BK and JC polyomaviruses. Immunity. 2019;50(3):668\u201376. e5.","DOI":"10.1016\/j.immuni.2019.02.003"},{"issue":"10","key":"4100_CR41","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1099\/vir.0.82094-0","volume":"87","author":"J Li","year":"2006","unstructured":"Li J, Melenhorst J, Hensel N, Rezvani K, Sconocchia G, Kilical Y, et al. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. J Gen Virol. 2006;87(10):2951\u201360.","journal-title":"J Gen Virol"},{"issue":"8016","key":"4100_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630(8016):493\u2013500.","journal-title":"Nature"},{"issue":"3","key":"4100_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41592-024-02174-0","volume":"21","author":"B Shor","year":"2024","unstructured":"Shor B, Schneidman-Duhovny D. Combfold: predicting structures of large protein assemblies using a combinatorial assembly algorithm and AlphaFold2. Nat Methods. 2024;21(3):477\u201387.","journal-title":"Nat Methods"},{"issue":"W1","key":"4100_CR44","doi-asserted-by":"publisher","first-page":"W431","DOI":"10.1093\/nar\/gkv495","volume":"43","author":"H Lee","year":"2015","unstructured":"Lee H, Heo L, Lee MS, Seok C. Galaxypepdock: a protein\u2013peptide docking tool based on interaction similarity and energy optimization. Nucleic Acids Res. 2015;43(W1):W431\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"4100_CR45","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"LC Xue","year":"2016","unstructured":"Xue LC, Rodrigues JP, Kastritis PL, Bonvin AM, Vangone A. PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics. 2016;32(23):3676\u20138.","journal-title":"Bioinformatics"},{"issue":"W1","key":"4100_CR46","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco JR, Aliaga JI, Quintana-Ort\u00ed ES, Chac\u00f3n P. iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res. 2014;42(W1):W271\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4100_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nprot.2016.169","volume":"12","author":"D Kozakov","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, Porter KA, Padhorny D, Yueh C, et al. The ClusPro web server for protein\u2013protein docking. Nat Protoc. 2017;12(2):255\u201378.","journal-title":"Nat Protoc"},{"issue":"4","key":"4100_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin N, Lund O, Bernaschi M, Castiglione F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One. 2010;5(4):e9862.","journal-title":"PLoS One"},{"issue":"22","key":"4100_CR49","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1103\/PhysRevLett.79.4493","volume":"79","author":"S Succi","year":"1997","unstructured":"Succi S, Castiglione F, Bernaschi M. Collective dynamics in the immune system response. Phys Rev Lett. 1997;79(22):4493.","journal-title":"Phys Rev Lett"},{"issue":"1","key":"4100_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1021\/acs.jpcb.3c06662","volume":"128","author":"P Eastman","year":"2023","unstructured":"Eastman P, Galvelis R, Pel\u00e1ez RP, Abreu CR, Farr SE, Gallicchio E, et al. OpenMM 8: molecular dynamics simulation with machine learning potentials. J Phys Chem B. 2023;128(1):109\u201316.","journal-title":"J Phys Chem B"},{"issue":"1-3","key":"4100_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","volume":"91","author":"HJ Berendsen","year":"1995","unstructured":"Berendsen HJ, van der Spoel D, van Drunen R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput Phys Commun. 1995;91(1\u20133):43\u201356.","journal-title":"Comput Phys Commun"},{"issue":"1","key":"4100_CR52","first-page":"17","volume":"24","author":"S Alizadeh","year":"2021","unstructured":"Alizadeh S, Moazen S, Faraji SN, Moattari A, Nejatollahi F. Novel single-chain antibodies against highly conserved epitopes in the hemagglutinin of influenza A viruses: promising agents for universal therapies. Iran J Basic Med Sci. 2021;24(1):17.","journal-title":"Iran J Basic Med Sci"},{"issue":"3","key":"4100_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030417","volume":"8","author":"Y Chan","year":"2020","unstructured":"Chan Y, Jazayeri SD, Ramanathan B, Poh CL. Enhancement of tetravalent immune responses to highly conserved epitopes of a dengue peptide vaccine conjugated to polystyrene nanoparticles. Vaccines. 2020;8(3):417.","journal-title":"Vaccines"},{"issue":"1","key":"4100_CR54","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2025.2517137","volume":"32","author":"G Sinani","year":"2025","unstructured":"Sinani G, \u015eenel S. Advances in vaccine adjuvant development and future perspectives. Drug Deliv. 2025;32(1):2517137.","journal-title":"Drug Deliv"},{"key":"4100_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1557415","volume":"16","author":"J Xing","year":"2025","unstructured":"Xing J, Zhao X, Li X, Fang R, Sun M, Zhang Y, et al. The recent advances in vaccine adjuvants. Front Immunol. 2025;16:1557415.","journal-title":"Front Immunol"},{"key":"4100_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-022-09351-3","author":"Y Mohammadi","year":"2022","unstructured":"Mohammadi Y, Nezafat N, Negahdaripour M, Eskandari S, Zamani M. In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach. Immunol Res. 2022. https:\/\/doi.org\/10.1007\/s12026-022-09351-3.","journal-title":"Immunol Res"},{"issue":"7","key":"4100_CR57","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1021\/acs.biomac.1c00481","volume":"22","author":"H Choi","year":"2021","unstructured":"Choi H, Eom S, Kim H-u, Bae Y, Jung HS, Kang S. Load and display: engineering encapsulin as a modular nanoplatform for protein-cargo encapsulation and protein-ligand decoration using split intein and SpyTag\/SpyCatcher. Biomacromolecules. 2021;22(7):3028\u201339.","journal-title":"Biomacromolecules"},{"issue":"31","key":"4100_CR58","doi-asserted-by":"publisher","first-page":"20083","DOI":"10.1021\/acsnano.4c00949","volume":"18","author":"S Bhattacharya","year":"2024","unstructured":"Bhattacharya S, Jenkins MC, Keshavarz-Joud P, Bourque AR, White K, Alvarez Barkane AM, et al. Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing. ACS Nano. 2024;18(31):20083\u2013100.","journal-title":"ACS Nano"},{"issue":"9","key":"4100_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12091020","volume":"12","author":"H-G Jung","year":"2024","unstructured":"Jung H-G, Jeong S, Kang M-J, Hong I, Park Y-S, Ko E, et al. Molecular design of encapsulin protein nanoparticles to display rotavirus antigens for enhancing immunogenicity. Vaccines. 2024;12(9):1020.","journal-title":"Vaccines"},{"issue":"7","key":"4100_CR60","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.1021\/acsomega.4c10285","volume":"10","author":"SN G\u00f3mez-Barrera","year":"2025","unstructured":"G\u00f3mez-Barrera SN, Delgado-Tapia W\u00c1, Hern\u00e1ndez-Guti\u00e9rrez AE, Cayetano-Cruz M, M\u00e9ndez C, Bustos-Jaimes I. Surface engineering of the encapsulin nanocompartment of Myxococcus xanthus for cell-targeted protein delivery. ACS Omega. 2025;10(7):7142\u201352.","journal-title":"ACS Omega"},{"issue":"3","key":"4100_CR61","first-page":"424","volume":"89","author":"L Duan","year":"2016","unstructured":"Duan L, Mukherjee E. Janeway\u2019s immunobiology. Yale J Biol Med. 2016;89(3):424.","journal-title":"Yale J Biol Med"},{"issue":"3","key":"4100_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nri3803","volume":"15","author":"S Crotty","year":"2015","unstructured":"Crotty S. A brief history of T cell help to B cells. Nat Rev Immunol. 2015;15(3):185\u20139.","journal-title":"Nat Rev Immunol"},{"issue":"26","key":"4100_CR63","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1056\/NEJMra033540","volume":"351","author":"PF Halloran","year":"2004","unstructured":"Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004;351(26):2715\u201329.","journal-title":"N Engl J Med"},{"issue":"11","key":"4100_CR64","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10(11):787\u201396.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4100_CR65","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1172\/JCI200422674","volume":"114","author":"JA Berzofsky","year":"2004","unstructured":"Berzofsky JA, Ahlers JD, Janik J, Morris J, Oh S, Terabe M, et al. Progress on new vaccine strategies against chronic viral infections. J Clin Invest. 2004;114(4):450\u201362.","journal-title":"J Clin Invest"},{"issue":"10","key":"4100_CR66","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/TP.0b013e3181bca422","volume":"88","author":"A Egli","year":"2009","unstructured":"Egli A, K\u00f6hli S, Dickenmann M, Hirsch HH. Inhibition of polyomavirus BK-specific T-cell responses by immunosuppressive drugs. Transplantation. 2009;88(10):1161\u20138.","journal-title":"Transplantation"},{"issue":"2","key":"4100_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/v14020209","volume":"14","author":"J Furmaga","year":"2022","unstructured":"Furmaga J, Kowalczyk M, Furmaga O, Rokos CA, Zapolski T, Krakowski L, et al. Molecular epidemiology and variation of the BK polyomavirus in the population of central and eastern Europe based on the example of Poland. Viruses. 2022;14(2):209.","journal-title":"Viruses"},{"issue":"2","key":"4100_CR68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1128\/CMR.00074-16","volume":"30","author":"GR Ambalathingal","year":"2017","unstructured":"Ambalathingal GR, Francis RS, Smyth MJ, Smith C, Khanna R. BK polyomavirus: clinical aspects, immune regulation, and emerging therapies. Clin Microbiol Rev. 2017;30(2):503\u201328.","journal-title":"Clin Microbiol Rev"},{"issue":"16","key":"4100_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163914","volume":"20","author":"U Moens","year":"2019","unstructured":"Moens U, Macdonald A. Effect of the large and small T-antigens of human polyomaviruses on signaling pathways. Int J Mol Sci. 2019;20(16):3914.","journal-title":"Int J Mol Sci"},{"key":"4100_CR70","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001020","author":"F Hopfner","year":"2021","unstructured":"Hopfner F, M\u00f6hn N, Eiz-Vesper B, Maecker-Kolhoff B, Gottlieb J, Blasczyk R, et al. Allogeneic BK virus-specific T-cell treatment in 2 patients with progressive multifocal leukoencephalopathy. Neurology Neuroimmunology & Neuroinflammation. 2021. https:\/\/doi.org\/10.1212\/NXI.0000000000001020.","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"issue":"1","key":"4100_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1102","volume":"9","author":"GR Ambalathingal","year":"2020","unstructured":"Ambalathingal GR, Francis RS, Corvino D, Srihari S, Aftab BT, Smith C, et al. Proteome\u2010wide analysis of T\u2010cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile. Clinical & translational immunology. 2020;9(1):e01102.","journal-title":"Clinical & translational immunology"},{"issue":"1","key":"4100_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-4-47","volume":"4","author":"M Provenzano","year":"2006","unstructured":"Provenzano M, Bracci L, Wyler S, Hudolin T, Sais G, Gosert R, et al. Characterization of highly frequent epitope-specific CD45RA+\/CCR7+\/-T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A* 0201+ BKV-seropositive donors. J Transl Med. 2006;4(1):1\u201315.","journal-title":"J Transl Med"},{"issue":"11","key":"4100_CR73","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1097\/TP.0b013e318234e0e5","volume":"92","author":"H Trydzenskaya","year":"2011","unstructured":"Trydzenskaya H, Sattler A, M\u00fcller K, Schachtner T, Dang-Heine C, Friedrich P, et al. Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity. Transplantation. 2011;92(11):1269\u201377.","journal-title":"Transplantation"},{"issue":"1","key":"4100_CR74","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/ajt.16233","volume":"21","author":"I Benotmane","year":"2021","unstructured":"Benotmane I, Solis M, Velay A, Cognard N, Olagne J, Gautier Vargas G, et al. Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV\u2010associated nephropathy in kidney transplant recipients\u2014Results from a proof\u2010of\u2010concept study. Am J Transplant. 2021;21(1):329\u201337.","journal-title":"Am J Transplant"},{"issue":"1","key":"4100_CR75","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s44319-024-00324-1","volume":"26","author":"RD Van Gelder","year":"2025","unstructured":"Van Gelder RD, Gokhale NS, Genoyer E, Omelia DS, Anderson SK, Young HA, et al. Interleukin-2-mediated NF-\u03baB-dependent mRNA splicing modulates interferon gamma protein production. EMBO Rep. 2025;26(1):16\u201335.","journal-title":"EMBO Rep"},{"issue":"4","key":"4100_CR76","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4331\/wjbc.v13.i4.72","volume":"13","author":"M Rybicka-Ramos","year":"2022","unstructured":"Rybicka-Ramos M, Markiewicz M, Suszka-\u015awitek A, Wiaderkiewicz R, Mizia S, Dzier\u017cak-Miet\u0142a M, et al. Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation. World J Biol Chem. 2022;13(4):72.","journal-title":"World J Biol Chem"},{"issue":"8","key":"4100_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087350","volume":"24","author":"NA A. Rahman","year":"2023","unstructured":"A. Rahman NA, Balasubramaniam VR, Yap WB. Potential of interleukin (IL)-12 group as antivirals: severe viral disease prevention and management. Int J Mol Sci. 2023;24(8):7350.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4100_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010675","volume":"13","author":"J Hatami","year":"2025","unstructured":"Hatami J, Das K, Wolf L, Aufschnaiter A, Kimpel J, Nolden T, et al. Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotype. J Immunother Cancer. 2025;13(8):e010675.","journal-title":"J Immunother Cancer"},{"key":"4100_CR79","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2025.1001352","volume":"6","author":"HA Lawal","year":"2025","unstructured":"Lawal HA, Raji AO, Olayiwola AE, Suleiman ZA, Muiz W, Lawal AO, et al. Overcoming barriers to the implementation of interleukin-12-based strategies in cancer immunotherapy: translational challenges, clinical integration, and public health implications. Exploration of Medicine. 2025;6:1001352.","journal-title":"Exploration of Medicine"},{"issue":"9","key":"4100_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/v11090772","volume":"11","author":"Y Guo","year":"2019","unstructured":"Guo Y, Cao W, Zhu Y. Immunoregulatory functions of the IL-12 family of cytokines in antiviral systems. Viruses. 2019;11(9):772.","journal-title":"Viruses"},{"issue":"6","key":"4100_CR81","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/01.TP.0000438115.20198.89","volume":"97","author":"D Vu","year":"2014","unstructured":"Vu D, Sakharkar P, Shah T, Naraghi R, Yasir Q, Hutchinson I, et al. Association of interferon gamma gene polymorphisms with BK virus infection among Hispanic renal allograft recipients. Transplantation. 2014;97(6):660\u20137.","journal-title":"Transplantation"},{"issue":"1","key":"4100_CR82","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1128\/JVI.01571-06","volume":"81","author":"JR Abend","year":"2007","unstructured":"Abend JR, Low JA, Imperiale MJ. Inhibitory effect of gamma interferon on BK virus gene expression and replication. J Virol. 2007;81(1):272\u20139.","journal-title":"J Virol"},{"issue":"4","key":"4100_CR83","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01072-3","volume":"27","author":"A Mauthe","year":"2025","unstructured":"Mauthe A, Cedrone E, Villar-Hern\u00e1ndez R, Rusch E, Springer M, Schuster M, et al. Ifn-\u03b3\/il-2 double-color fluorospot assay for monitoring human primary t cell activation: validation, inter-laboratory comparison, and recommendations for clinical studies. AAPS J. 2025;27(4):81.","journal-title":"AAPS J"},{"issue":"5","key":"4100_CR84","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.4049\/jimmunol.1202256","volume":"190","author":"Q Sa","year":"2013","unstructured":"Sa Q, Woodward J, Suzuki Y. IL-2 produced by CD8+ immune T cells can augment their IFN-\u03b3 production independently from their proliferation in the secondary response to an intracellular pathogen. J Immunol. 2013;190(5):2199\u2013207.","journal-title":"J Immunol"},{"key":"4100_CR85","doi-asserted-by":"publisher","DOI":"10.1615\/critrevimmunol.v32.i1.30","author":"SS Iyer","year":"2012","unstructured":"Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Critical Reviews\u2122 in Immunology. 2012. https:\/\/doi.org\/10.1615\/critrevimmunol.v32.i1.30.","journal-title":"Critical Reviews\u2122 in Immunology"},{"key":"4100_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1161067","volume":"14","author":"V Carlini","year":"2023","unstructured":"Carlini V, Noonan DM, Abdalalem E, Goletti D, Sansone C, Calabrone L, et al. The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol. 2023;14:1161067.","journal-title":"Front Immunol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04100-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:02:14Z","timestamp":1788544934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04100-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":86,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4100"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04100-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare they have no financial or non-financial competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare they have no financial or non-financial competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}